Moreover, SGI treatment significantly upregulated the expression of Mfn1, Mfn2 and Opa1 (Figure 10C) compared with that in the DOX group, which suggested that SGI could regulate mitochondrial dynamics alterations in DCM. The gene discussed is OPA1; the disease is familial dilated cardiomyopathy.